Laboratory/Pathology policy updates
Track new and updated Laboratory/Pathology policies impacting reimbursement and clinical operations.
| Policy | Payer | Type | Specialty | Change | Effective |
|---|---|---|---|---|---|
| Hepatitis Testing | Blue Cross Blue Shield - Texas | Clinical | Laboratory/Pathology | Modified | Nov 7, 2025 |
| Diagnostic Testing of Influenza | Blue Cross Blue Shield - Texas | Clinical | Laboratory/Pathology | Modified | Sep 25, 2025 |
| Pathogen Panel Testing | Blue Cross Blue Shield - Texas | Clinical | Laboratory/Pathology | Modified | Aug 1, 2025 |
| Gamma-glutamyl Transferase in Adults | Blue Cross Blue Shield - Texas | Clinical | Laboratory/Pathology | Modified | May 15, 2025 |
| Hepatitis Testing | Blue Cross Blue Shield - Texas | Clinical | Laboratory/Pathology | Modified | May 15, 2025 |
| Vitamin D Testing (25‑hydroxyvitamin D and 1,25‑dihydroxyvitamin D) Coverage and Reimbursement Criteria | Blue Cross Blue Shield - Texas | Clinical | Laboratory/Pathology | Modified | May 15, 2025 |
| Urine Culture Testing for Bacteria | Blue Cross Blue Shield - Texas | Clinical | Laboratory/Pathology | Modified | Jan 1, 2025 |
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.
OpenPayer by Trek Health — Policy intelligence for billing and revenue cycle teams.
Coverage data is sourced from publicly available payer medical policy documents and updated as payers publish revisions. Read more about where our data comes from. Always consult the primary payer source for clinical decision-making.